A major new review has put hundreds of alternative autism treatments under the microscope—and most didn’t hold up. Scientists ...
Scientists at Duke-NUS Medical School have developed two powerful computational tools that could transform how researchers ...
Lunit’s new collaboration with Daiichi Sankyo integrates AI-driven digital pathology tools into oncology translational ...
Beacon Biosignals, a leader in AI-driven neurophysiology and precision drug development, today announced a collaboration with Harmony Biosciences (Nasdaq: HRMY), a pharmaceutical company dedicated to ...
For decades, patients undergoing blood cancer treatment have been told to avoid certain foods to reduce infection risk, ...
A brain-dedicated scanner is changing what doctors can see. CT researchers say that ‘opens the door’
The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...
SNMMI, EANM, and ARTnet launch unified PET accreditation to improve clinical trials and patient care
Three world-leading nuclear medicine organizations--the SNMMI Clinical Trials Network (SNMMI-CTN), the Australasian Radiopharmaceutical Trials Network (ARTnet), and the European Association of Nuclear ...
The study explains that energy use in data centres is dominated by two processes: computing and cooling. Together, they ...
FLAMeS, a new convolutional neural network, enhances MS lesion segmentation accuracy using only T2-weighted FLAIR images, ...
Discover the latest breakthroughs in myasthenia gravis treatment, including rozanolixizumab and nipocalimab, and insights on ...
Vietnam Investment Review on MSN
Taiwan pioneers early kidney disease annual report in Asia Pacific
TAIPEI, TAIWAN - Media OutReach Newswire - 11 December 2025 - Taiwan's chronic disease care is once again at the forefront internationally, taking new strides with the release of the Asia-Pacific's ...
As investors grow wary of AI-driven mega-cap concentration, the WisdomTree U.S. Value Fund offers a compelling alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results